Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Calothrixin B, whose structure consists of a pentacyclic indolo[3,2-
j
]phenanthridine framework, was originally isolated as a secondary metabolite from
Calothrix
cyanobacteria and was found to exhibit potent antiproliferative activity. In this study, treatment with 100 μM of calothrixin B did not inhibit the proliferation of HL-60 promyelocytic leukemia cells, the result indicated that calothrixin B could possess weaker activity against leukemia cells. In a previous study of the structure–antiproliferative activity relationships of calothrixin B analogs, the tetracyclic 5
H
-pyrido[4,3-
b
]carbazole-4,11(6
H
)-dione structure, which does not include the benzene ring found in calothrixin B, was reported to be necessary for antiproliferative activity; however, the induction of substituents on the indole nitrogen atom of calothrixin B decreased the antiproliferative activity of the compound. To develop calothrixin B analogs with good antiproliferative activity against both HL-60 and HCT-116 cells, we synthesized various
N
-substituted calothrixin B analogs and assessed their activity. Compared with calothrixin B,
N
-OMe calothrixin B displayed almost the same or slightly stronger antiproliferative activity against HCT-116 cells, whereas the
N
-MOM analog demonstrated slightly weaker activity against these cells. These two analogs also inhibited proliferation of HL-60 cells, whereas calothrixin B did not exhibit antiproliferative activity toward these cells. Among calothrixin B analogs,
N
-OMe and
N
-MOM calothrixins B are cytotoxic against HCT-116 cells and not the lack of the effect on HL-60 cells.